Start spreading the news
Adwords: interacting with consumers
Medical advertising is highly regulated. The advertising of prescription medicine is even prohibited.
This is the result of European legislation— Article 88 (1)(a) of Community Directive 2001/83—that has been implemented in national legislation.
In a German case (C-316/09) that eventually reached the Court of Justice for the EU (CJEU), pharmaceutical company Merckle contested the diffusion, by its competitor MSD Sharp & Dohme, of information about prescription medicines on its website. Merckle said that by acting in this way, MSD had breached the law prohibiting advertising for medicines, and in so doing, it displayed unfair behaviour. Indeed, Merckle won.
However, MSD argued—in its last appeal before the Bundesgerichtshof (the German Federal Supreme Court)—that the material in question was information that was commonly available to any consumer, as the material was limited to a reproduction of the packaging of the product, the therapeutic indication and the notice of use. MSD said that this was not advertising.
To continue reading, you need a subscription to WIPR. Start a subscription to WIPR for £455.
In-house feature articles, the archive and expert comment require a paid subscription. Subscribe now.
Want to give it a try? We are offering a two week free trial to the WIPR website – register and select “Free Trial” to begin access to the full WIPR archive and read the latest news, features and expert comment. Begin your free trial here.
Is your 2 week free trial about to end? Upgrade to a 12 month subscription for £455 now.
If you have already subscribed please login.
If you have any technical issues please email tech support.